VPU-deficient HIV strains stimulate innate immune signaling responses in target cells

Journal of Virology

Volumn 86, Issue 16, 2012, Pages 8499-8506

  Doehle, Brian P ^a   Chang, Kristina ^a   Fleming, Lamar ^b   McNevin, John ^b   Hladik, Florian ^a,b   McElrath, M Juliana ^a,b   Gale, Michael ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 3; MYELOID DIFFERENTIATION FACTOR 88; PATTERN RECOGNITION RECEPTOR; VPU PROTEIN;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE INDUCTION; HOST CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOREGULATION; IMMUNOSTIMULATION; INNATE IMMUNITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS IMMUNITY; VIRUS INDUCTION; VIRUS STRAIN;

ADULT; CELLS, CULTURED; FEMALE; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES; MACROPHAGES; SIGNAL TRANSDUCTION; VIRAL REGULATORY AND ACCESSORY PROTEINS;

EID: 84865069404     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00424-12     Document Type: Article

References (54)

1. Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124:783-801.
2. Beignon AS, et al. 2005. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viralRNAinteractions. J. Clin. Invest. 115:3265-3275.
3. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B Methodol. 57:289-300.
4. Blazejczk M, Miron M, Nadon R. 2007. Presented at the Genome, Montreal, Quebec, Canada.
5. Bosinger SE, et al. 2004. Gene expression profiling of host response in models of acute HIV infection. J. Immunol. 173:6858-6863.
6. Co JG, Witwer KW, Gama L, Zink MC, Clements JE. 2011. Induction of innate immune responses by SIV in vivo and in vitro: differential expression and function of RIG-I and MDA5. J. Infect. Dis. 204:1104-1114.
7. de Veer MJ, et al. 2001. Functional classification of interferon-stimulated genes identified using microarrays. J. Leukoc. Biol. 69:912-920.
8. Doehle BP, et al. 2012. Vpu mediates depletion of interferon regulatory factor 3 during HIV infection by a lysosome-dependent mechanism. J. Virol. 8367-8374.
9. Doehle BP, Gale M, Jr. 2012. Innate immune evasion strategies of HCV and HIV: common themes for chronic viral infection. In Sambhara S, Fujita T. (ed), Nucleic acid sensors and antiviral immunity. Landes Bioscience, Austin, TX.
10. Doehle BP, Hladik F, McNevin JP, McElrath MJ, Gale M, Jr. 2009. Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells. J. Virol. 83:10395-10405.
11. Doitsh G, et al. 2010. Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell 143:789-801.
12. Douglas JL, et al. 2010. The great escape: viral strategies to counter BST-2/tetherin. PLoS Pathog. 6:e1000913. doi:10.1371/journal.ppat. 1000913.
13. Douglas JL, et al. 2009. Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/tetherin via a {beta}TrCPdependent mechanism. J. Virol. 83:7931-7947.
14. Du P, Kibbe WA, Lin SM. 2008. lumi: a pipeline for processing Illumina microarray. Bioinformatics 24:1547-1548.
15. Dunning MJ, Barbosa-Morais NL, Lynch AG, Tavaré S, Ritchie ME. 2008. Statistical issues in the analysis of Illumina data. BMC Bioinformatics 9:85. doi:10.1186/1471-2105-9-85.
16. Espert L, et al. 2005. Interferon-induced exonuclease ISG20 exhibits an antiviral activity against human immunodeficiency virus type 1. J. Gen. Virol. 86:2221-2229.
17. Geiss GK, et al. 2000. Large-scale monitoring of host cell gene expression during HIV-1 infection using cDNA microarrays. Virology 266:8-16.
18. Grandvaux N, et al. 2002. Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J. Virol. 76:5532-5539.
19. Harman AN, et al. 2011. HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production. Blood 118:298-308.
20. Hladik F, et al. 1999. Dendritic cell-T-cell interactions support coreceptor-independent human immunodeficiency virus type 1 transmission in the human genital tract. J. Virol. 73:5833-5842.
21. Hladik F, Lentz G, Delpit E, McElroy A, McElrath MJ. 1999. Coexpression of CCR5 and IL-2 in human genital but not blood T cells: implications for the ontogeny of the CCR5() Th1 phenotype. J. Immunol. 163: 2306-2313.
22. Honda K, et al. 2005. IRF-7 is the master regulator of type-I interferondependent immune responses. Nature 434:772-777.
23. Iwabu Y, et al. 2009. HIV-1 accessory protein Vpu internalizes cellsurface BST-2/tetherin through transmembrane interactions leading to lysosomes. J. Biol. Chem. 284:35060-35072.
24. Kawai T, Akira S. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11:373-384.
25. Kirchhoff F. 2010. Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. Cell Host Microbe 8:55-67.
26. Lin SM, Du P, Huber W, Kibbe WA. 2008. Model-based variancestabilizing transformation for Illumina microarray data. Nucleic Acids Res. 36:e11.
27. Long AD, et al. 2001. Improved statistical inference from DNA microarray data using analysis of variance and a Bayesian statistical framework. Analysis of global gene expression in Escherichia coli K12. J. Biol. Chem. 276:19937-19944.
28. Loo YM, et al. 2008. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 82:335-345.
29. Loo YM, Gale M, Jr. 2007. Viral regulation and evasion of the host response. Curr. Top. Microbiol. Immunol. 316:295-313.
30. Loo YM, Gale M, Jr. 2011. Immune signaling by RIG-I-like receptors. Immunity 34:680-692.
31. Mandl JN, et al. 2008. Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat. Med. 14:1077-1087.
32. Manel N, et al. 2010. A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 467:214-217.
33. Margottin F, et al. 1998. A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell 1:565-574.
34. Meier A, et al. 2007. MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands. J. Virol. 81:8180-8191.
35. Mitchell RS, et al. 2009. Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking. PLoS Pathog. 5:e1000450. doi:10.1371/journal.ppat.1000450.
36. Neil S, Bieniasz P. 2009. Human immunodeficiency virus, restriction factors, and interferon. J. Interferon Cytokine Res. 29:569-580.
37. Ockenhouse CF, Bernstein WB, Wang ZN, Vahey MT. 2005. Functional genomic relationships in HIV-1 disease revealed by gene-expression profiling of primary human peripheral blood mononuclear cells. J. Infect. Dis. 191:2064-2074.
38. Okumura A, et al. 2008. HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation. Virology 373:85-97.
39. Okumura A, Lu GS, Pitha-Rowe I, Pitha PM. 2006. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc. Natl. Acad. Sci. U. S. A. 103:1440-1445.
40. Pasare C, Medzhitov R. 2004. Toll-like receptors: linking innate and adaptive immunity. Microbes Infect. 6:1382-1387.
41. Pertel T, et al. 2011. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472:361-365.
42. Richards KH, Clapham PR. 2007. Effects of Vpu start-codon mutations on human immunodeficiency virus type 1 replication in macrophages. J. Gen. Virol. 88:2780-2792.
43. Rivieccio MA, et al. 2006. TLR3 ligation activates an antiviral response in human fetal astrocytes: a role for viperin/cig5. J. Immunol. 177:4735-4741.
44. Sadler AJ, Williams BRG. 2008. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8:559-568.
45. Saeed AI, et al. 2006. TM4 microarray software suite. Methods Enzymol. 411:134-193.
46. Saeed AI, et al. 2003. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34:374-378.
47. Saito T, Owen DM, Jiang FG, Marcotrigiano J, Gale M. 2008. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454:523-527.
48. Schaefer TM, et al. 2006. Increased expression of interferon-inducible genes in macaque lung tissues during simian immunodeficiency virus infection. Microbes Infect. 8:1839-1850.
49. Solis M, et al. 2011. RIG-I-mediated antiviral signaling is inhibited in HIV-1 infection by a protease-mediated sequestration of RIG-I. J. Virol. 85:1224-1236.
50. Stetson DB, Medzhitov R. 2006. Type I interferons in host defense. Immunity 25:373-381.
51. Suthar MS, et al. 2010. IPS-1 is essential for the control of West Nile virus infection and immunity. PLoS Pathog. 6:e1000757. doi:10.1371/ journal.ppat.1000757.
52. Wilkins C, Gale M, Jr. 2010. Recognition of viruses by cytoplasmic sensors. Curr. Opin. Immunol. 22:41-47.
53. Woelk CH, et al. 2004. Interferon gene expression following HIV type 1 infection of monocyte-derived macrophages. AIDS Res. Hum. Retroviruses 20:1210-1222.
54. Yan N, Regalado-Magdos AD, Stiggelbout B, Lee-Kirsch MA, Lieberman J. 2010. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat. Immunol. 11:1005-1013.